Hemodynamic Forces Affect Endothelial Cell Pheotype in Arterial Disease

血流动力学影响动脉疾病中的内皮细胞表型

基本信息

  • 批准号:
    7464627
  • 负责人:
  • 金额:
    $ 38.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-10 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The fluid wall shear stress (WSS) driven by blood flow and the solid circumferential strain (CS) and associated circumferential stress driven by blood pressure act simultaneously on endothelial cells (ECs) lining blood vessels to modulate their phenotype. In recent dynamic computer simulations we showed that CS and WSS are most asynchronous (out-of-phase temporally) in precisely those regions of the circulation where atherosclerotic disease is most prominent (e.g., coronary arteries, carotid sinus). Our recent in vitro experiments have revealed a striking gene expression profile that is pro-atherogenic when CS and WSS are imposed asynchronously. We have observed a similar gene expression profile in the coronary arteries of rabbits. However, most studies of hemodynamic forces and atherogenesis have suggested that certain characteristics of WSS by itself induce an atherogenic phenotype without reference to CS or the interaction of CS and WSS. In the proposed research we will pursue the following studies in order to demonstrate the crucial role of the combined forces of CS and WSS and their phasic relationship in generating an atherogenic phenotype in endothelial cells in discrete regions of the circulation: 1. ECs grown on the inner surfaces of elastic tubes will be exposed to combined CS and WSS either synchronously or asynchronously, with a mean WSS that is either high or low. Gene expression profiles (48 genes) and EC turnover rates will be compared. The hypothesis is that asynchrony of forces will dominate mean WSS level in controlling EC phenotype. 2. The detailed biomolecular mechanism by which the eNOS gene is regulated when WSS and CS are applied synchronously or asynchronously will be determined as a first step toward understanding how these forces conspire to control EC phenotype. 3. The gene expression profiles (48 genes) of rabbit coronary arteries and carotid bifurcations (atherogenic) and common carotid arteries and femoral arteries (non-atherogenic) will be compared. The nutraceutical, conjugated linoleic acid (CLA), that was able to normalize atherogenic gene expression profiles in vitro, will be tested in the rabbit model to determine whether it can similarly alter EC phenotype in vivo. Project Narrative: The research is important to public health because it will determine which fundamental aspect of the mechanical environment of endothelial cells predisposes certain vessels (e.g., coronary arteries) to cardiovascular disease. In addition, the research will consider for the first time the possibility that pharmaceutical agents may normalize the pro-atherogenic endothelial phenotype induced by the mechanical environment inherent in the design of the cardiovascular system. This could ultimately lead to new drugs for the treatment of cardiovascular disease.
描述(申请人提供):由血流驱动的流体壁切应力(WSS)和由血压驱动的固体周向应变(CS)和相关的周向应力同时作用于血管衬里的内皮细胞(ECs)以调节其表型。在最近的动态计算机模拟中,我们发现CS和WSS在动脉粥样硬化疾病最突出的循环区域(例如冠状动脉、颈动脉窦)是最不同步的(在时间上是不同步的)。我们最近的体外实验揭示了一个惊人的基因表达谱,当CS和WSS被异步施加时,它是促进动脉粥样硬化的。我们在兔的冠状动脉中观察到了类似的基因表达谱。然而,大多数关于血流动力和动脉粥样硬化形成的研究表明,WSS的某些特性本身就会导致动脉粥样硬化的表型,而不涉及CS或CS和WSS的相互作用。在拟议的研究中,我们将进行以下研究,以证明CS和WSS的合力在循环离散区域内皮细胞产生动脉粥样硬化表型中的关键作用及其相态关系:1.生长在弹性管内表面的ECs将同步或异步地暴露于CS和WSS的组合中,平均WSS或高或低。将比较基因表达谱(48个基因)和EC周转率。假说是,在控制EC表型方面,力量的不同步将主导平均WSS水平。2.当WSS和CS同时或异步应用时,eNOS基因调控的详细生物分子机制将被确定为了解这些力量如何共同控制EC表型的第一步。3.比较兔冠状动脉和颈动脉分叉(致动脉粥样硬化)和颈总动脉和股动脉(非致动脉粥样硬化)的基因表达谱(48个基因)。能够在体外使致动脉粥样硬化基因表达谱正常化的营养食品共轭亚油酸(CLA)将在兔模型中进行测试,以确定它是否能在体内类似地改变EC的表型。 项目简介:这项研究对公众健康很重要,因为它将确定内皮细胞机械环境的哪个基本方面使某些血管(例如冠状动脉)易患心血管疾病。此外,这项研究将首次考虑药物可以使心血管系统设计中固有的机械环境诱导的促动脉粥样硬化内皮细胞表型正常化的可能性。这最终可能导致治疗心血管疾病的新药问世。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M TARBELL其他文献

JOHN M TARBELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M TARBELL', 18)}}的其他基金

The Endothelial Glycocalyx: Its Structure and Function and as a Mechanotransducer
内皮糖萼:其结构和功能以及作为机械传感器
  • 批准号:
    7887862
  • 财政年份:
    2010
  • 资助金额:
    $ 38.95万
  • 项目类别:
The Endothelial Glycocalyx: Its Structure and Function and as a Mechanotransducer
内皮糖萼:其结构和功能以及作为机械传感器
  • 批准号:
    8289879
  • 财政年份:
    2010
  • 资助金额:
    $ 38.95万
  • 项目类别:
The Endothelial Glycocalyx: Its Structure and Function and as a Mechanotransducer
内皮糖萼:其结构和功能以及作为机械传感器
  • 批准号:
    8247713
  • 财政年份:
    2010
  • 资助金额:
    $ 38.95万
  • 项目类别:
The Endothelial Glycocalyx: Its Structure and Function and as a Mechanotransducer
内皮糖萼:其结构和功能以及作为机械传感器
  • 批准号:
    8056011
  • 财政年份:
    2010
  • 资助金额:
    $ 38.95万
  • 项目类别:
The Endothelial Glycocalyx: Its Structure and Function and as a Mechanotransducer
内皮糖萼:其结构和功能以及作为机械传感器
  • 批准号:
    8452129
  • 财政年份:
    2010
  • 资助金额:
    $ 38.95万
  • 项目类别:
The Endothelial Glycocalyx: Its Structure and Function and as a Mechanotransducer
内皮糖萼:其结构和功能以及作为机械传感器
  • 批准号:
    8825611
  • 财政年份:
    2010
  • 资助金额:
    $ 38.95万
  • 项目类别:
Hemodynamic Forces Affect Endothelial Cell Pheotype in Arterial Disease
血流动力学影响动脉疾病中的内皮细胞表型
  • 批准号:
    7610927
  • 财政年份:
    2008
  • 资助金额:
    $ 38.95万
  • 项目类别:
Hemodynamic Forces Affect Endothelial Cell Pheotype in Arterial Disease
血流动力学影响动脉疾病中的内皮细胞表型
  • 批准号:
    7788858
  • 财政年份:
    2008
  • 资助金额:
    $ 38.95万
  • 项目类别:
CCNY/MSKCC Biomedical Engineering Partnership
CCNY/MSKCC 生物医学工程合作伙伴
  • 批准号:
    7128549
  • 财政年份:
    2005
  • 资助金额:
    $ 38.95万
  • 项目类别:
CCNY/MSKCC Biomedical Engineering Partnership
CCNY/MSKCC 生物医学工程合作伙伴
  • 批准号:
    7283534
  • 财政年份:
    2005
  • 资助金额:
    $ 38.95万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 38.95万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 38.95万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 38.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了